(Deamino-Cys1,b-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin trifluoroacetate salt
CAS: 136105-89-0
Rif. 3D-FD108862
1mg | 241,00 € | ||
2mg | 393,00 € | ||
5mg | 700,00 € | ||
10mg | 1.067,00 € | ||
25mg | 2.319,00 € |
Informazioni sul prodotto
- d(D-3Pal)VP
- [Deamino-Cys1
- D-3-(Pyridyl)Ala2
- Arg8] Vasopressin3-Mercaptopropionyl-?-(3-pyridyl)-D-Ala-Phe-Gln-Asn-Cys-Pro-Arg-Gly -NH2 trifluoroacetate salt (Disulfide bond)
- Argipressin, 1-deamino-3-(3'-pyridyl)-ala(2)-
- 1-Deamino-3-(3'-pyridyl)-2-ala-argipressin
- Argipressin, 1-deamino-3-(3'-pyridyl)alanine(2)-
- d(D-3-Pal)VP
- 1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-6,9,12,15,18-pentaoxo-16-(pyridin-3-ylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyl-N~5~-(diaminomethylidene)ornithylglycinamide
- 3-Mercaptopropionyl-Beta-3-Pyridyl-D-Ala-Phe-Gln-Asn-Cys-Pro-Arg-Gly-Nh2
- Vedi altri sinonimi
DDAVP is an analogue of vasopressin, which belongs to the class of inositol phosphates. It is a potent agonist for the V1 receptor and has a higher affinity for this receptor than vasopressin. DDAVP also has antagonist properties at the V2 receptor. The biological activity of DDAVP is mediated by its ability to increase phospholipase A2 activity and cause the release of arachidonic acid from membrane phospholipids. This activation causes an increase in prostaglandin synthesis, leading to increased vascular permeability and hypotension. DDAVP may also have antidiuretic effects due to its antagonism of oxytocin receptors.
Proprietà chimiche
Richiesta tecnica su: 3D-FD108862 (Deamino-Cys1,b-(3-pyridyl)-D-Ala2,Arg8)-Vasopressin trifluoroacetate salt
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.